Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4

Journal Article · · J. Med. Chem.
; ; ; ; ; ; ; ; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1845476
Journal Information:
J. Med. Chem., Vol. 65, Issue (3)
Country of Publication:
United States
Language:
ENGLISH

References (76)

Chronic obstructive pulmonary disease December 2015
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease April 2004
Central Role of the NF-κB Pathway in the Scgb1a1 -Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation June 2018
BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection January 2017
Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition June 2017
NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns April 2017
Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling April 2019
Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation April 2018
Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling August 2019
Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling January 2020
Targeting bromodomains: epigenetic readers of lysine acetylation April 2014
The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation February 2007
Phospho-BRD4: transcription plasticity and drug targeting March 2016
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency March 2018
BET domain co-regulators in obesity, inflammation and cancer June 2012
Opposing Functions of BRD4 Isoforms in Breast Cancer June 2020
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure May 2017
Brd4 modulates the innate immune response through Mnk2–eIF4E pathway-dependent translational control of IκBα May 2017
Down-regulation of NF-κB Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition May 2012
Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases November 2021
Reactivation of Latent HIV-1 by Inhibition of BRD4 October 2012
BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression August 2016
Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580 May 2020
Discovery of RSV-Induced BRD4 Protein Interactions Using Native Immunoprecipitation and Parallel Accumulation—Serial Fragmentation (PASEF) Mass Spectrometry March 2021
Bromodomain Containing Protein 4 (BRD4) Regulates Expression of its Interacting Coactivators in the Innate Response to Respiratory Syncytial Virus October 2021
BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice August 2015
Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity November 2015
Drug Discovery Targeting Bromodomain-Containing Protein 4 March 2017
A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression July 2020
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain November 2013
Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer July 2018
Selective inhibition of BET bromodomains September 2010
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials April 2015
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer January 2020
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor October 2017
Direct Activation of Bax Protein for Cancer Therapy: DIRECT ACTIVATION OF Bax FOR CANCER THERAPY September 2015
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma March 2018
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation March 2020
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4 June 2015
Plasticity in binding confers selectivity in ligand-induced protein degradation June 2018
Emerging paradigms in GPCR allostery: implications for drug discovery August 2013
Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development February 2021
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins April 2015
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family March 2012
What makes a good drug target? February 2012
Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation May 2018
Efficacy of Novel Highly Specific Bromodomain-Containing Protein 4 Inhibitors in Innate Inflammation–Driven Airway Remodeling January 2019
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation April 2020
Bacterial Reduction as Means for Colonic Drug Delivery: Can Other Chemical Groups Provide an Alternative to the Azo Bond? November 2012
Structure-activity relationships of 2-substituted phenyl- N -phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs) December 2017
Affinity Map of Bromodomain Protein 4 (BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1 March 2014
Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior November 2020
Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT 2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties June 2020
4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading November 2013
Discovery of Chemical Inhibitors of Human Bromodomains October 2015
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors March 2014
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites March 2020
Targeting epigenetic machinery: Emerging novel allosteric inhibitors December 2019
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts August 2018
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders January 2009
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders September 2014
Analysis of Protein Stability and Ligand Interactions by Thermal Shift Assay February 2015
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery March 2002
GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications January 2019
Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT 2C Receptor April 2018
Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV July 2019
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation October 2012
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM March 2011
How good are my data and what is the resolution? June 2013
PHENIX: a comprehensive Python-based system for macromolecular structure solution January 2010
Features and development of Coot March 2010
Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility June 2013
Discovery of O -Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents January 2013
7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents August 2011
Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting March 2013
Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler September 2000

Similar Records

Related Subjects